SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-004312
Filing Date
2020-03-19
Accepted
2020-03-19 07:01:28
Documents
91
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm 20-F 2973796
2 ex2-7.htm EX-2.7 59816
3 ex12-1.htm EX-12.1 18076
4 ex12-2.htm EX-12.2 17705
5 ex13-1.htm EX-13.1 9952
6 ex15-1.htm EX-15.1 4443
7 form20-f_001.jpg GRAPHIC 44132
8 form20-f_002.jpg GRAPHIC 20937
9 form20-f_003.jpg GRAPHIC 9874
10 auditor_001.jpg GRAPHIC 1694
  Complete submission text file 0001493152-20-004312.txt   8152715

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE vblt-20191231.xml EX-101.INS 1390916
12 XBRL SCHEMA FILE vblt-20191231.xsd EX-101.SCH 75483
13 XBRL CALCULATION FILE vblt-20191231_cal.xml EX-101.CAL 65925
14 XBRL DEFINITION FILE vblt-20191231_def.xml EX-101.DEF 218733
15 XBRL LABEL FILE vblt-20191231_lab.xml EX-101.LAB 435951
16 XBRL PRESENTATION FILE vblt-20191231_pre.xml EX-101.PRE 342903
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 20726394
SIC: 2834 Pharmaceutical Preparations